Associate Professor of Ophthalmology

Vitreoretinal Surgical Service

Medical school

University of Chicago, Pritzker School of Medicine

Residency

Wilmer Ophthalmological Institute at Johns Hopkins Medical Institutions

Fellowship(s)

Wilmer Ophthalmological Institute at Johns Hopkins Medical Institutions

Background

Sharon Fekrat, MD, FACS, specializes in the diagnosis and medical and surgical management of vitreoretinal disease. She is currently the President of the North Carolina Society of Eye Physicians and Surgeons.

Phone

919.681.0341

Fax

919.681.6474

Research Interests

Fekrat has a particular interest in novel therapeutic options for central, branch and hemi retinal vein occlusion as well as eyes with neovascular age-related macular degeneration. She is the site's principal investigator for many ongoing clinical trials for retinal vein occlusion and age-related macular degeneration. She is actively involved in evaluating these options in eligible individuals. 

Representative Publications

1. Deramo V, Cox TA, Syed A, Lee PP, Fekrat S: Vision related quality of life in patients with central retinal vein occlusion using the 25-item National Eye Institute visual function questionnaire (VFQ-25). Arch Ophthalmol 2003; 121: 1297-1302.
2. Weizer J, Stinnett S, Fekrat S: Radial optic neurotomy for central retinal vein occlusion. Am J Ophthalmol 2003; 136: 814-19.
3. Cahill M, Kaiser P, Fekrat S: The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003; 87: 1329-32.
4. Cahill M, Stinnett S, Fekrat S: Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003; 136: 1136-50.
5. Czjaka M, McCuen BM, Toth CA, Fekrat S: Radial optic neurotomy in a porcine eye without a vein occlusion. Arch Ophthalmol 2004; 122: 1185-9.
6. Siddiqui N, Fekrat S: Group 2A idiopathic juxtafoveolar telangiectasia in monozygotic twins. Am J Ophthalmol 2005; 139: 568-70.
7. Meyer CH, Lapolice D, Fekrat S: Functional changes after photodynamic therapy with verteporfin. Am J Ophthalmol 2005, 139: 214-5.